Cargando…

Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains

Dysregulation of microRNA gene expression has been implicated in many neurodegenerative diseases, including Parkinson’s disease. However, the individual dysregulated microRNAs remain largely unknown. Previous meta-analyses have highlighted several microRNAs being differentially expressed in post-mor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dobricic, Valerija, Schilling, Marcel, Farkas, Ildiko, Gveric, Djordje O, Ohlei, Olena, Schulz, Jessica, Middleton, Lefkos, Gentleman, Steve M, Parkkinen, Laura, Bertram, Lars, Lill, Christina M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645562/ https://www.ncbi.nlm.nih.gov/pubmed/36382223 http://dx.doi.org/10.1093/braincomms/fcac274

Ejemplares similares

Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer’s disease
por: Sommerer, Yasmine, et al.
Publicado: (2023)

Differential microRNA expression analyses across two brain regions in Alzheimer’s disease
por: Dobricic, Valerija, et al.
Publicado: (2022)

A correlation map of genome-wide DNA methylation patterns between paired human brain and buccal samples
por: Sommerer, Yasmine, et al.
Publicado: (2022)

Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variants
por: Prokopenko, Inga, et al.
Publicado: (2019)

Epigenome-Wide Association Study in Peripheral Tissues Highlights DNA Methylation Profiles Associated with Episodic Memory Performance in Humans
por: Sommerer, Yasmine, et al.
Publicado: (2022)

Genetic risk scores and hallucinations in patients with Parkinson disease
por: Kusters, Cynthia D.J., et al.
Publicado: (2020)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
por: Konijnenberg, Elles, et al.
Publicado: (2020)

Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease
por: Pey, Peixuan, et al.
Publicado: (2014)

Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer’s and Parkinson’s disease
por: Liu, Alan King Lun, et al.
Publicado: (2015)

Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
por: Tsalenchuk, Maria, et al.
Publicado: (2023)

Genotype–Phenotype Relations for the Atypical Parkinsonism Genes:MDSGene Systematic Review
por: Wittke, Christina, et al.
Publicado: (2021)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
por: Homann, Jan, et al.
Publicado: (2022)

Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions
por: Skundric, Dusanka S, et al.
Publicado: (2006)

Genetic risk for Alzheimer disease predicts hippocampal volume through the human lifespan
por: Walhovd, Kristine B., et al.
Publicado: (2020)

Diabetes mellitus, prediabetes and the risk of Parkinson’s disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases
por: Aune, Dagfinn, et al.
Publicado: (2023)

NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease
por: Sastre, Magdalena, et al.
Publicado: (2010)

WDR45 mutations may cause a MECP2 mutation-negative Rett syndrome phenotype
por: Kulikovskaja, Leonora, et al.
Publicado: (2018)

Development of the CHARIOT Research Register for the Prevention of Alzheimer’s Dementia and Other Late Onset Neurodegenerative Diseases
por: Larsen, Mark E., et al.
Publicado: (2015)

Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition
por: Nido, Gonzalo S., et al.
Publicado: (2020)

Multisystem screening reveals SARS‐CoV‐2 in neurons of the myenteric plexus and in megakaryocytes
por: Gray‐Rodriguez, Sandra, et al.
Publicado: (2022)

Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases
por: Doroszkiewicz, Julia, et al.
Publicado: (2023)

Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29
por: Raffel, Joel, et al.
Publicado: (2017)

Common genetic variants associated with Parkinson’s disease display widespread signature of epigenetic plasticity
por: Sharma, Amit, et al.
Publicado: (2019)

Evaluation of the Common Molecular Basis in Alzheimer’s and Parkinson’s Diseases
por: Rana, Pratip, et al.
Publicado: (2019)

Common genetic signatures of Alzheimer’s disease in Down Syndrome
por: Sharma, Ayati, et al.
Publicado: (2021)

Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases
por: Wilson, Heather, et al.
Publicado: (2020)

Common microRNA regulated pathways in Alzheimer’s and Parkinson’s disease
por: Awuson-David, Betina, et al.
Publicado: (2023)

Brain Regional Differences in Hexanucleotide Repeat Length in X-Linked Dystonia-Parkinsonism Using Nanopore Sequencing
por: Reyes, Charles Jourdan, et al.
Publicado: (2021)

Prognostic cancer gene signatures share common regulatory motifs
por: Wang, Ying, et al.
Publicado: (2017)

Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease
por: Keo, Arlin, et al.
Publicado: (2020)

An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia
por: Berlyand, Yosef, et al.
Publicado: (2016)

Features of the Skin Microbiota in Common Inflammatory Skin Diseases
por: Ferček, Iva, et al.
Publicado: (2021)

Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort
por: Zhao, Yujia, et al.
Publicado: (2023)

Transcriptomic Signatures Associated With Regional Cortical Thickness Changes in Parkinson’s Disease
por: Keo, Arlin, et al.
Publicado: (2021)

A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia
por: Nicolaou, Paschalis, et al.
Publicado: (2008)

Transition from physical to virtual visit format for a longitudinal brain aging study, in response to the Covid‐19 pandemic. Operationalizing adaptive methods and challenges
por: Udeh‐Momoh, Chinedu Theresa, et al.
Publicado: (2020)

Multimodal Imaging Signatures of Parkinson's Disease
por: Bowman, F. DuBois, et al.
Publicado: (2016)

Functional Connectivity Signatures of Parkinson’s Disease
por: Tessitore, Alessandro, et al.
Publicado: (2019)

Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology()
por: Petzold, Axel, et al.
Publicado: (2008)

Considerations in establishing a post-mortem brain and tissue bank for the study of myalgic encephalomyelitis/chronic fatigue syndrome: a proposed protocol
por: Nacul, Luis, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0c6diq47ellk0k4n7s5pb71932